| The influence of probiotics on the firmicutes/bacteroidetes ratio in the treatment of obesity and inflammatory bowel disease S Stojanov, A Berlec, B Štrukelj Microorganisms 8 (11), 1715, 2020 | 943 | 2020 |
| Current state and recent advances in biopharmaceutical production in Escherichia coli, yeasts and mammalian cells A Berlec, B Štrukelj Journal of industrial microbiology and biotechnology 40 (3-4), 257-274, 2013 | 286 | 2013 |
| Non-immunoglobulin scaffolds: a focus on their targets K Škrlec, B Štrukelj, A Berlec Trends in biotechnology 33 (7), 408-418, 2015 | 235 | 2015 |
| Novel techniques and findings in the study of plant microbiota: search for plant probiotics A Berlec Plant science 193, 96-102, 2012 | 166 | 2012 |
| Electrospun nanofibers as carriers of microorganisms, stem cells, proteins, and nucleic acids in therapeutic and other applications S Stojanov, A Berlec Frontiers in bioengineering and biotechnology 8, 130, 2020 | 132 | 2020 |
| Development of electrospun nanofibers that enable high loading and long-term viability of probiotics K Škrlec, Š Zupančič, SP Mihevc, P Kocbek, J Kristl, A Berlec European Journal of Pharmaceutics and Biopharmaceutics 136, 108-119, 2019 | 114 | 2019 |
| Safety aspects of genetically modified lactic acid bacteria TV Plavec, A Berlec Microorganisms 8 (2), 297, 2020 | 96 | 2020 |
| Single plasmid systems for inducible dual protein expression and for CRISPR-Cas9/CRISPRi gene regulation in lactic acid bacterium Lactococcus lactis A Berlec, K Škrlec, J Kocjan, M Olenic, B Štrukelj Scientific reports 8 (1), 1009, 2018 | 90 | 2018 |
| Lactic acid bacteria as oral delivery systems for biomolecules A Berlec, M Ravnikar, B Štrukelj Die Pharmazie-An International Journal of Pharmaceutical Sciences 67 (11 …, 2012 | 70 | 2012 |
| Effects of electrospinning on the viability of ten species of lactic acid bacteria in poly (ethylene oxide) nanofibers Š Zupančič, K Škrlec, P Kocbek, J Kristl, A Berlec Pharmaceutics 11 (9), 483, 2019 | 69 | 2019 |
| Engineering of lactic acid bacteria for delivery of therapeutic proteins and peptides TV Plavec, A Berlec Applied microbiology and biotechnology 103, 2053-2066, 2019 | 60 | 2019 |
| In vivo imaging of Lactococcus lactis, Lactobacillus plantarum and Escherichia coli expressing infrared fluorescent protein in mice A Berlec, J Završnik, M Butinar, B Turk, B Štrukelj Microbial cell factories 14, 1-14, 2015 | 47 | 2015 |
| Expression of the sweet-tasting plant protein brazzein in Escherichia coli and Lactococcus lactis: a path toward sweet lactic acid bacteria A Berlec, Z Jevnikar, AČ Majhenič, I Rogelj, B Štrukelj Applied microbiology and biotechnology 73, 158-165, 2006 | 47 | 2006 |
| Improvement of LysM-mediated surface display of designed ankyrin repeat proteins (DARPins) in recombinant and nonrecombinant strains of Lactococcus lactis and Lactobacillus Species P Zadravec, B Štrukelj, A Berlec Applied and environmental microbiology 81 (6), 2098-2106, 2015 | 46 | 2015 |
| Engineered Lactic Acid Bacterium Lactococcus lactis Capable of Binding Antibodies and Tumor Necrosis Factor Alpha M Ravnikar, B Štrukelj, N Obermajer, M Lunder, A Berlec Applied and environmental microbiology 76 (20), 6928-6932, 2010 | 45 | 2010 |
| Identification of Candidate Carrier Proteins for Surface Display on Lactococcus lactis by Theoretical and Experimental Analyses of the Surface Proteome A Berlec, P Zadravec, Z Jevnikar, B Štrukelj Applied and Environmental Microbiology 77 (4), 1292-1300, 2011 | 44 | 2011 |
| Optimization of fermentation conditions for the expression of sweet‐tasting protein brazzein in Lactococcus lactis A Berlec, G Tompa, N Slapar, UP Fonović, I Rogelj, B Štrukelj Letters in applied microbiology 46 (2), 227-231, 2008 | 39 | 2008 |
| Lactic acid bacteria with concomitant IL-17, IL-23 and TNFα-binding ability for the treatment of inflammatory bowel disease S Kosler, B Strukelj, A Berlec Current Pharmaceutical Biotechnology 18 (4), 318-326, 2017 | 35 | 2017 |
| Dextran sulphate sodium colitis in C57BL/6J mice is alleviated by Lactococcus lactis and worsened by the neutralization of tumor necrosis factor α A Berlec, M Perše, M Ravnikar, M Lunder, A Erman, A Cerar, B Štrukelj International Immunopharmacology 43, 219-226, 2017 | 35 | 2017 |
| Large increase in brazzein expression achieved by changing the plasmid /strain combination of the NICE system in Lactococcus lactis A Berlec, B Štrukelj Letters in applied microbiology 48 (6), 750-755, 2009 | 35 | 2009 |
